Grimes & Company’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,029
Closed -$290K 414
2025
Q1
$290K Sell
4,029
-85,640
-96% -$6.97M 0.01% 297
2024
Q4
$7.72M Sell
89,669
-25,392
-22% -$2.53M 0.22% 87
2024
Q3
$10.9M Buy
115,061
+2,217
+2% +$197K 0.29% 77
2024
Q2
$10.8M Buy
112,844
+40,181
+55% +$4.78M 0.32% 72
2024
Q1
$9.57M Buy
72,663
+31,701
+77% +$3.9M 0.29% 80
2023
Q4
$5.92M Sell
40,962
-4,894
-11% -$672K 0.2% 91
2023
Q3
$7.8M Buy
+45,856
New +$9.14M 0.3% 78
2021
Q4
Sell
-976
Closed -$214K 299
2021
Q3
$214K Buy
+976
New +$208K 0.01% 278
2020
Q2
Sell
-80,854
Closed -$4.56M 250
2020
Q1
$4.56M Buy
80,854
+8,392
+12% +$643K 0.42% 60
2019
Q4
$5.29M Sell
72,462
-296
-0.4% -$19.8K 0.35% 72
2019
Q3
$5.06M Buy
72,758
+4,655
+7% +$317K 0.36% 68
2019
Q2
$4.79M Buy
68,103
+7,993
+13% +$590K 0.36% 68
2019
Q1
$4.93M Buy
60,110
+5,755
+11% +$471K 0.39% 69
2018
Q4
$4.19M Sell
54,355
-762
-1% -$71.9K 0.41% 61
2018
Q3
$5.5M Buy
55,117
+4,034
+8% +$390K 0.44% 64
2018
Q2
$4.82M Buy
51,083
+2,743
+6% +$263K 0.43% 69
2018
Q1
$4.48M Buy
48,340
+3,765
+8% +$415K 0.43% 64
2017
Q4
$5.7M Sell
44,575
-800
-2% -$109K 0.55% 59
2017
Q3
$6.18M Sell
45,375
-331
-0.7% -$39.4K 0.66% 46
2017
Q2
$4.82M Sell
45,706
-1,305
-3% -$142K 0.54% 58
2017
Q1
$4.97M Sell
47,011
-10,211
-18% -$994K 0.54% 55
2016
Q4
$4.93M Sell
57,222
-1,124
-2% -$95.1K 0.57% 53
2016
Q3
$4.99M Sell
58,346
-8,374
-13% -$690K 0.67% 49
2016
Q2
$5.29M Buy
66,720
+5,770
+9% +$424K 0.71% 37
2016
Q1
$3.9M Sell
60,950
-4,462
-7% -$245K 0.5% 58
2015
Q4
$3.66M Sell
65,412
-1,791
-3% -$92.2K 0.49% 59
2015
Q3
$2.96M Buy
67,203
+4,074
+6% +$199K 0.38% 69
2015
Q2
$3.49M Buy
63,129
+6,023
+11% +$360K 0.49% 64
2015
Q1
$3.02M Buy
57,106
+7,383
+15% +$403K 0.73% 60
2014
Q4
$2.99M Buy
49,723
+149
+0.3% +$8.78K 0.77% 55
2014
Q3
$2.92M Buy
+49,574
New +$3.22M 0.76% 58

Other funds holding ALB

Grimes & Company's ALB Position: Q2 2025 in Review

Grimes & Company sold out of Albemarle (ALB) in Q2 2025, closing a stake of 4,029 shares — an estimated $290K sold.

Grimes & Company first reported a position in ALB in Q3 2014 and held it in 31 quarters. The position peaked at $10.9M in Q3 2024. 699 funds tracked by Wall St. Rank hold ALB as of Q2 2025.

  • Grimes & Company reported no remaining Albemarle position as of Q2 2025 after selling out during the quarter.
  • Grimes & Company sold 4,029 Albemarle shares in Q2 2025, an estimated $290K.
  • Grimes & Company first reported a position in Albemarle in Q3 2014 and held it in 31 quarters.
  • Grimes & Company's Albemarle position peaked at $10.9M in Q3 2024.
  • 699 funds tracked by Wall St. Rank held Albemarle as of Q2 2025.

Based on Grimes & Company's 13F filing for Q2 2025, filed 22 Jul 2025.